# Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage

> **NCT00375258** · PHASE3 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 20211 (actual)

## Conditions studied

- Hemorrhage

## Interventions

- **DRUG:** Tranexamic acid
- **DRUG:** Sodium Chloride 0.9%

## Key facts

- **NCT ID:** NCT00375258
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2010-02
- **Final completion:** 2010-03
- **Target enrollment:** 20211 (ACTUAL)
- **Last updated:** 2011-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00375258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00375258, "Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00375258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*